Interpace Biosciences, Inc. (IDXG)
1.13
+0.08
(+7.62%)
USD |
OTCM |
Jan 09, 16:00
Interpace Biosciences Profit Margin (Quarterly): 11.55% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| FONAR Corp. | 10.25% |
| XWELL, Inc. | -2.87% |
| ProPhase Labs, Inc. | -774.5% |
| Veracyte, Inc. | 14.51% |
| Insight Molecular Diagnostics, Inc. | -4.17K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 30.26% |
| Return on Invested Capital | 283.2% |
| Gross Profit Margin (Quarterly) | 62.12% |
| Operating Margin (Quarterly) | 13.08% |
| Return on Net Operating Assets | 33.84% |